Back to INBX

Bank of New York Mellon Corp → INBX

Bank of New York Mellon Corp INBX Position History

Inhibrx Biosciences, Inc. • Healthcare

Quarters held
14
Latest value
$100
Q3 2026
Peak value
$1.8M
First seen
Q4 2025

Dollar value over time

Show data table
PeriodPosition value
Q4 2025$797K
Q4 2025$1.3M
Q4 2025$7K
Q1 2026$678K
Q1 2026$1.1M
Q1 2026$6K
Q2 2026$832K
Q2 2026$1.6M
Q2 2026$8K
Q2 2026$95
Q3 2026$759K
Q3 2026$1.8M
Q3 2026$8K
Q3 2026$100

Quarter-by-quarter history

Every disclosed snapshot of the position

QuarterValueShares% PortfolioChange
Q3 2026$1001——
Q3 2026$8K83——
Q3 2026$1.8M18.5K——
Q3 2026$759K7.6K——
Q2 2026$951——
Q2 2026$8K83——
Q2 2026$1.6M17.3K——
Q2 2026$832K8.8K——
Q1 2026$6K83——
Q1 2026$1.1M15.7K——
Q1 2026$678K10.1K——
Q4 2025$7K83——
Q4 2025$1.3M16.6K——
Q4 2025$797K10.1K——

Other funds holding INBX

Other Bank of New York Mellon Corp positions

NVDA

NVIDIA CORP

$15.1B
NVDA

NVIDIA CORP

$14B
NVDA

NVIDIA CORP

$13.6B
NVDA

NVIDIA CORP

$12.7B
AAPL

APPLE INC

$12.5B
AAPL

APPLE INC

$12.1B
AAPL

APPLE INC

$11.6B
MSFT

MICROSOFT CORP

$11.1B